Last week the FDA rejected the weight loss pill lorcaserin. This week they have rejected Vivus Inc.’s drug, Qnexa. This represents quite a setback for those trying to get a handle on obesity in America. This is also the third weight loss pill to be rejected this month. In July, a panel of experts had […]